NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW
2,040.00
-90.00 (-4.23%)
At close: Feb 20, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 5.69B | 4.35B | 11.02B | 7.16B |
Medical Labs & Research Growth | 30.80% | -60.51% | 53.81% | - |
| 5.69B | 4.35B | 11.02B | 7.16B |
| 30.80% | -60.51% | 53.81% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 3.14B | 4.12B | 9.80B | 5.97B |
| -23.81% | -58.01% | 64.35% | - |
| 2.55B | 233.96M | 1.21B | 1.20B |
| 991.71% | -80.71% | 1.28% | - |
| 5.69B | 4.35B | 11.02B | 7.16B |
| 30.80% | -60.51% | 53.81% | - |
Source: S&P Global Market Intelligence.
